Patent · US Active

Hydrogel drug delivery composition

US12419811B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · US

Inventors

Dong Wang · Hefei, CN
Yosif Almoshari · Abha, SA
Rongguo Ren · Omaha, US
Ningrong Chen · Omaha, US

Key dates

Filing date	Apr 20, 2020
Grant date	Sep 23, 2025
Priority date	—
Expiry date	Oct 11, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a hydrogel drug delivery composition comprising a therapeutic agent and a poloxamer, wherein the poloxamer is modified to be capable of adhering to a surface of bones or teeth, and wherein the poloxamer is modified by pyrophosphate, bisphosphonates, acidic peptides or tetracycline and its derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.